Morepen Laboratories · NSE: MOREPENLAB · BSE: 500288
Q1 FY19 results · Apr–Jun 2018
Morepen Laboratories reported revenue from operations of ₹163.73 crore and net profit of ₹2.46 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 163.73 | — | — | — | — |
| Other income | 0.08 | — | — | — | — |
| Total income | 163.80 | — | — | — | — |
| Profit before tax | 2.65 | — | — | — | — |
| Net profit for the period | 2.46 | — | — | — | — |
| EPS, basic (₹) | 0.05 | — | — | — | — |
| Net margin (%) | 1.5 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 150.84 | — | — | — | — |
| Other income | 0.08 | — | — | — | — |
| Total income | 150.91 | — | — | — | — |
| Profit before tax | 2.55 | — | — | — | — |
| Net profit for the period | 2.36 | — | — | — | — |
| EPS, basic (₹) | 0.05 | — | — | — | — |
| Net margin (%) | 1.6 | — | — |
Consolidated
- Filed with BSE
- 17 Aug 2018, 18:20 IST
- Board meeting
- 13 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 Aug 2018, 18:20 IST
- Board meeting
- 13 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE